» Articles » PMID: 15671192

Changes in Age at Diagnosis of Type 2 Diabetes Mellitus in the United States, 1988 to 2000

Overview
Journal Ann Fam Med
Specialty Public Health
Date 2005 Jan 27
PMID 15671192
Citations 110
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The prevalence of diabetes in the United States is increasing. There is also concern that diabetes may be occurring at a greater frequency in youth and in young adults. We describe US population trends in self-reported age at diagnosis of type 2 diabetes mellitus.

Methods: We undertook a secondary analysis of data from the National Health and Nutrition Examination Survey (NHANES) 1999-2000 and NHANES III (1988-1994). Both surveys are stratified, multistage probability samples targeting the civilian, noninstitutionalized US population, which allow calculation of population estimates. We included adults aged 20 years and older. We compared self-reported age at diagnosis of type 2 diabetes between the 2 survey periods.

Results: The mean age at diagnosis decreased from 52.0 to 46.0 years (P <.05). Racial and ethnic differences in age at diagnosis found in 1988 to 1994 are no longer found in 1999 to 2000.

Conclusions: The age at diagnosis of type 2 diabetes mellitus has decreased with time. This finding likely represents a combination of changing diagnostic criteria, improved physician recognition of diabetes, and increased public awareness. Younger age at diagnosis may also reflect a true population trend of earlier onset of type 2 diabetes.

Citing Articles

Incidence of diabetic retinopathy and predictors among adult patients with diabetes in central and southern Ethiopia: a multicentre retrospective cohort study.

Yakob T, Abraham A, Yakob B, Jaldo M BMJ Open. 2025; 15(1):e090916.

PMID: 39842931 PMC: 11784131. DOI: 10.1136/bmjopen-2024-090916.


Racial/Ethnic Disparities in Access to Transportation Among Persons with Type 2 Diabetes Mellitus.

McClintock H, Edmonds S, Wang E J Racial Ethn Health Disparities. 2025; .

PMID: 39804504 DOI: 10.1007/s40615-024-02262-z.


Inter-trial Variation in the Sensitivity of Thermal Threshold Testing for the Diagnosis of Neuropathy in Type 2 Diabetes Mellitus.

Gaur A, Varatharajan S, Taranikanti M, John N, Kalpana M, Ganji V Int J Appl Basic Med Res. 2024; 14(3):182-186.

PMID: 39310082 PMC: 11412566. DOI: 10.4103/ijabmr.ijabmr_207_24.


The Prevalence of Comorbidities Associated with Multiple Sclerosis in Saudi Arabia.

Alnajashi H, Wali A, Aqeeli A, Magboul A, Alfulayt M, Baasher A Ann Afr Med. 2024; 23(4):600-605.

PMID: 39138964 PMC: 11556490. DOI: 10.4103/aam.aam_49_24.


Biomarkers of Neurodegeneration and Alzheimer's Disease Neuropathology in Adolescents and Young Adults with Youth-Onset Type 1 or Type 2 Diabetes: A Proof-of-Concept Study.

Shapiro A, Coughlan C, Bettcher B, Pauley M, Kim J, Bjornstad P Endocrines. 2024; 5(2):197-213.

PMID: 38764894 PMC: 11101213. DOI: 10.3390/endocrines5020014.


References
1.
. WHO Expert Committee on Diabetes Mellitus: second report. World Health Organ Tech Rep Ser. 1980; 646:1-80. View

2.
Mokdad A, Ford E, Bowman B, Dietz W, Vinicor F, Bales V . Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2002; 289(1):76-9. DOI: 10.1001/jama.289.1.76. View

3.
. The cost-effectiveness of screening for type 2 diabetes. CDC Diabetes Cost-Effectiveness Study Group, Centers for Disease Control and Prevention. JAMA. 1998; 280(20):1757-63. View

4.
Flegal K, Carroll M, Ogden C, Johnson C . Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002; 288(14):1723-7. DOI: 10.1001/jama.288.14.1723. View

5.
Ogden C, Flegal K, Carroll M, Johnson C . Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA. 2002; 288(14):1728-32. DOI: 10.1001/jama.288.14.1728. View